STERIS plc
STE
Rang in Aktien
#1075
STERIS plc provides infection prevention products and services in the United... STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Aktienkurs
$221.33
Marktkapitalisierung
$21.58B
Veränderung (1 Tag)
-0.38%
Veränderung (1 Jahr)
-7.86%
Land
IE
Handel STERIS plc (STE)
Kategorie
Healthcare
Gewinn für STERIS plc (STE)
Gewinn im Jun 2026 TTM: $1.09B
Laut den aktuellen Finanzberichten von STERIS plc betragen die aktuellen Gewinne des Unternehmens $1.09B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $702.81M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $680.27M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von STERIS plc von 2000 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $1.09B | 36.76% |
| 2025 | $796.21M | 13.29% |
| 2024 | $702.81M | 3.31% |
| 2023 | $680.27M | 85.46% |
| 2022 | $366.80M | -29.12% |
| 2021 | $517.53M | 3.77% |
| 2020 | $498.75M | 35.15% |
| 2019 | $369.03M | 3.96% |
| 2018 | $354.98M | 92.25% |
| 2017 | $184.65M | 7.42% |
| 2016 | $171.88M | -17.69% |
| 2015 | $208.82M | 10.85% |
| 2014 | $188.38M | -17.05% |
| 2013 | $227.10M | 7.57% |
| 2012 | $211.11M | 185.98% |
| 2011 | $73.82M | -61.52% |
| 2010 | $191.82M | 15.22% |
| 2009 | $166.49M | 38.97% |
| 2008 | $119.80M | -9.88% |
| 2007 | $132.93M | 22.95% |
| 2006 | $108.12M | -21.82% |
| 2005 | $138.29M | 9.33% |
| 2004 | $126.49M | 1.91% |
| 2003 | $124.12M | 69.24% |
| 2002 | $73.34M | 1,173.88% |
| 2001 | $5.76M | -65.96% |
| 2000 | $16.91M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| $74.36M | -93.17% |
KR
|
